Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
20 | 1966633 | intron variant | A/G | snv | 2.0E-02 |
|
Cardiovascular Diseases | 0.700 | 1.000 | 1 | 2016 | 2016 | |||||||||
|
20 | 1970274 | intron variant | A/G | snv | 4.6E-03 |
|
0.700 | 1.000 | 1 | 2016 | 2016 | ||||||||||
|
20 | 1950251 | intron variant | T/A;C;G | snv |
|
0.700 | 1.000 | 1 | 2019 | 2019 | |||||||||||
|
20 | 1950251 | intron variant | T/A;C;G | snv |
|
0.700 | 1.000 | 1 | 2016 | 2016 | |||||||||||
|
20 | 1950239 | intron variant | G/A | snv | 0.43 |
|
0.700 | 1.000 | 1 | 2016 | 2016 | ||||||||||
|
20 | 2007953 | intron variant | A/C;T | snv |
|
Cardiovascular Diseases | 0.700 | 1.000 | 1 | 2008 | 2008 | ||||||||||
|
20 | 1950355 | intron variant | C/T | snv | 0.43 |
|
0.700 | 1.000 | 1 | 2016 | 2016 | ||||||||||
|
20 | 2014888 | intron variant | A/G | snv | 2.9E-02 |
|
0.700 | 1.000 | 1 | 2012 | 2012 | ||||||||||
|
0.790 | 0.200 | 20 | 1979293 | 3 prime UTR variant | G/A | snv | 0.37 |
|
Digestive System Diseases; Neoplasms | 0.010 | < 0.001 | 1 | 2014 | 2014 | |||||||
|
0.790 | 0.200 | 20 | 1979293 | 3 prime UTR variant | G/A | snv | 0.37 |
|
Chemically-Induced Disorders; Mental Disorders | 0.010 | < 0.001 | 1 | 2019 | 2019 | |||||||
|
0.790 | 0.200 | 20 | 1979293 | 3 prime UTR variant | G/A | snv | 0.37 |
|
Chemically-Induced Disorders; Mental Disorders | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||||
|
0.790 | 0.200 | 20 | 1979293 | 3 prime UTR variant | G/A | snv | 0.37 |
|
Chemically-Induced Disorders; Mental Disorders | 0.010 | 1.000 | 1 | 2011 | 2011 | |||||||
|
0.790 | 0.200 | 20 | 1979293 | 3 prime UTR variant | G/A | snv | 0.37 |
|
Behavior and Behavior Mechanisms | 0.010 | 1.000 | 1 | 2009 | 2009 | |||||||
|
0.790 | 0.200 | 20 | 1979293 | 3 prime UTR variant | G/A | snv | 0.37 |
|
Digestive System Diseases; Neoplasms | 0.010 | < 0.001 | 1 | 2014 | 2014 | |||||||
|
0.790 | 0.200 | 20 | 1979293 | 3 prime UTR variant | G/A | snv | 0.37 |
|
Chemically-Induced Disorders; Mental Disorders | 0.010 | 1.000 | 1 | 2009 | 2009 | |||||||
|
0.851 | 0.120 | 20 | 1994212 | 5 prime UTR variant | T/C | snv | 0.50 |
|
Chemically-Induced Disorders; Mental Disorders | 0.030 | 0.667 | 3 | 2009 | 2019 | |||||||
|
0.851 | 0.120 | 20 | 1994212 | 5 prime UTR variant | T/C | snv | 0.50 |
|
Chemically-Induced Disorders; Mental Disorders | 0.020 | 1.000 | 2 | 2013 | 2018 | |||||||
|
0.851 | 0.120 | 20 | 1979580 | 3 prime UTR variant | A/G | snv | 0.35 |
|
Chemically-Induced Disorders; Mental Disorders | 0.020 | 1.000 | 2 | 2018 | 2019 | |||||||
|
0.851 | 0.120 | 20 | 1994212 | 5 prime UTR variant | T/C | snv | 0.50 |
|
Nervous System Diseases; Mental Disorders | 0.010 | 1.000 | 1 | 2009 | 2009 | |||||||
|
0.851 | 0.120 | 20 | 1994212 | 5 prime UTR variant | T/C | snv | 0.50 |
|
Nervous System Diseases; Mental Disorders | 0.010 | 1.000 | 1 | 2009 | 2009 | |||||||
|
0.851 | 0.120 | 20 | 1979580 | 3 prime UTR variant | A/G | snv | 0.35 |
|
Chemically-Induced Disorders; Mental Disorders | 0.010 | 1.000 | 1 | 2011 | 2011 | |||||||
|
0.851 | 0.120 | 20 | 1979580 | 3 prime UTR variant | A/G | snv | 0.35 |
|
Nervous System Diseases; Mental Disorders | 0.010 | 1.000 | 1 | 2009 | 2009 | |||||||
|
0.851 | 0.120 | 20 | 1979580 | 3 prime UTR variant | A/G | snv | 0.35 |
|
Nervous System Diseases; Mental Disorders | 0.010 | 1.000 | 1 | 2009 | 2009 | |||||||
|
0.882 | 0.120 | 20 | 1989288 | intron variant | A/G | snv | 0.40 |
|
Chemically-Induced Disorders; Mental Disorders | 0.020 | 1.000 | 2 | 2013 | 2017 | |||||||
|
0.882 | 0.120 | 20 | 1989288 | intron variant | A/G | snv | 0.40 |
|
Nervous System Diseases; Mental Disorders | 0.010 | 1.000 | 1 | 2009 | 2009 |